
¡Activa las notificaciones laborales por email!
Genera un currículum adaptado en cuestión de minutos
Consigue la entrevista y gana más. Más información
A leading cancer research center in Badalona is seeking an experienced Program Coordinator to oversee new initiatives aimed at accelerating translational research in leukaemia. The role includes project management, stakeholder engagement, and ensuring compliance with funding rules. Ideal candidates have a PhD in life sciences and significant experience in managing international research collaborations, specifically in biomedical contexts.
The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC). Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting‑edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
The Josep Carreras Leukaemia Research Institute (IJC) is seeking an experienced Program Coordinator to coordinate two of the new initiatives included in the new IJC strategic plan, namely Path2Cure and 22nd Century Diagnosis Centre.
Path2Cure represents a transformative approach to therapeutic translation at the Josep Carreras Leukaemia Research Institute (IJC). While traditional drug development remains slow, costly, and fragmented, Path2Cure seeks to overcome these barriers by creating an integrated ecosystem that accelerates the full continuum from discovery to preclinical validation and clinical readiness. The program establishes IJC’s first comprehensive Translational Therapeutics Hub — a dedicated infrastructure uniting state‑of‑the‑art experimental models, predictive analytics, and strategic collaborations with clinical and industrial partners.
The Center for 22nd Century Diagnostics (C22D) will transform medicine by redefining diagnostics as holistic, dynamic, and predictive systems grounded in longitudinal data and multi‑modal AI. Combining the expertise of the Josep Carreras Institute, Barcelona Supercomputing Center, and Catalan hospitals, C22D will integrate spatial biology and systems modeling to create patient‑specific therapeutic roadmaps that anticipate disease evolution, identify intervention windows, and guide personalized therapies to prevent resistance and relapse.
Please submit your application by 05/12/2025.
The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world‑class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.
In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation.
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start‑up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.
The IJC is an equal‑opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.